Efficacy, Predictive Factors, and Prediction Nomograms for 68 Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy-Reference-Cited by-同舟云学术

Efficacy, Predictive Factors, and Prediction Nomograms for 68 Ga-labeled Prostate-specific Membrane Antigen–ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy

Published:2018-05 Issue:5 Volume:73 Page:656-661
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Rauscher Isabel,Düwel Charlotte,Haller Bernhard,Rischpler Christoph,Heck Matthias M.,Gschwend Jürgen E.,Schwaiger Markus,Maurer Tobias,Eiber Matthias^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference14 articles.

1. Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature;Ost;Eur Urol,2015

2. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years;Suardi;Eur Urol,2015

3. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients;Afshar-Oromieh;Eur J Nucl Med Mol Imaging,2017

4. Evaluation of hybrid (6)(8)Ga-PSMA ligand PET/CT in 248 patients with biochemical recurrence after radical prostatectomy;Eiber;J Nucl Med,2015

5. Sensitivity, specificity, and predictors of positive 68Ga-prostate-specific membrane antigen positron emission tomography in advanced prostate cancer: a systematic review and meta-analysis;Perera;Eur Urol,2016

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunohistochemistry analysis of PSMA expression at prostatic biopsy in high-risk prostate cancer: potential implications for PSMA-PET patient selection;Frontiers in Oncology;2024-05-14

2. Biochemical Response of <0.1 ng/ml Predicts Therapy-free Survival of Prostate Cancer Patients following Prostate-specific Membrane Antigen–targeted Salvage Surgery;European Urology Oncology;2024-05

3. Impact of Circulating Tumor Cell–Expressed Prostate-Specific Membrane Antigen and Prostate-Specific Antigen Transcripts in Different Stages of Prostate Cancer;Clinical Cancer Research;2024-04-08

4. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature;European Urology Oncology;2024-02

5. Current status of PSMA-targeted imaging and therapy;Frontiers in Oncology;2024-01-09